Protect Medicaid Act [HB-2856]
Prohibits federal payment under Medicaid for the administrative costs of providing health benefits to noncitizens who are ineligible for Medicaid based on their immigration status. The Department of Health and Human Services must report on specified information regarding states that provide health benefits to such individuals.
HB-2856: Protect Medicaid Act
Sponsored by: Rep. Mike Johnson
Referred To The Subcommittee On Health. on 05/22/2019
Opioid Crisis Accountability Act of 2019 [S.1584]
Establishes a series of restrictions and requirements relating to opioid marketing and distribution practices. Specifically, the bill prohibits (1) knowingly making false advertising or marketing claims regarding the addictive nature of opioids; (2) knowingly supplying communities with quantities of opioids that are not medically reasonable; or (3) failing to report distribution orders, or patterns of orders, while knowing that the orders are not being dispensed in a medically reasonable manner. Employees of opioid manufacturers and distributors
(continued...)
S.1584: Opioid Crisis Accountability Act of 2019
Sponsored by: Sen. Bernard Sanders
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/21/2019
Opioid Crisis Accountability Act of 2019 [S.1584]
Establishes a series of restrictions and requirements relating to opioid marketing and distribution practices. Specifically, the bill prohibits (1) knowingly making false advertising or marketing claims regarding the addictive nature of opioids; (2) knowingly supplying communities with quantities of opioids that are not medically reasonable; or (3) failing to report distribution orders, or patterns of orders, while knowing that the orders are not being dispensed in a medically reasonable manner. Employees of opioid manufacturers and distributors
(continued...)
S.1584: Opioid Crisis Accountability Act of 2019
Sponsored by: Sen. Bernard Sanders
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/21/2019
Pharmacy Benefit Manager Accountability Study Act of 2019 [S.1532]
A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
S.1532: Pharmacy Benefit Manager Accountability Study Act of 2019
Sponsored by: Sen. Marsha Blackburn
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/16/2019
Health Care Price Check Act of 2019 [S.1497]
Requires Medicare, Medicare Advantage, Medicare prescription drug plan sponsors, and private health insurers to have a toll-free phone number and website through which enrollees may obtain certain health insurance information. Among other items, the phone number and website must provide information relating to cost-sharing requirements, the quality of covered items and services, and out-of-network providers, as applicable.
S.1497: Health Care Price Check Act of 2019
Sponsored by: Sen. Ron Wyden
Read Twice And Referred To The Committee On Finance. on 05/15/2019
Safer Prescribing of Controlled Substances Act [HB-2734]
Establishes a new registration requirement for a practitioner (other than a hospital, pharmacy, or veterinarian) who is licensed to dispense or conduct research with a controlled substance in schedules II, III, IV, or V of the Controlled Substances Act. Specifically, the practitioner must comply with a training requirement as a condition of obtaining or renewing their registration. The training must include information on best practices for pain management and responsible prescribing of pain medications.
HB-2734: Safer Prescribing of Controlled Substances Act
Sponsored by: Rep. Yvette Clarke
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 06/26/2019
Safer Prescribing of Controlled Substances Act [HB-2734]
Establishes a new registration requirement for a practitioner (other than a hospital, pharmacy, or veterinarian) who is licensed to dispense or conduct research with a controlled substance in schedules II, III, IV, or V of the Controlled Substances Act. Specifically, the practitioner must comply with a training requirement as a condition of obtaining or renewing their registration. The training must include information on best practices for pain management and responsible prescribing of pain medications.
HB-2734: Safer Prescribing of Controlled Substances Act
Sponsored by: Rep. Yvette Clarke
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 06/26/2019
Safer Prescribing of Controlled Substances Act [S.1448]
Establishes a new registration requirement for a practitioner (other than a hospital, pharmacy, or veterinarian) who is licensed to dispense or conduct research with a controlled substance in schedules II, III, IV, or V of the Controlled Substances Act. Specifically, the practitioner must comply with a training requirement as a condition of obtaining or renewing their registration. The training must include information on best practices for pain management and responsible prescribing of pain medications.
S.1448: Safer Prescribing of Controlled Substances Act
Sponsored by: Sen. Dianne Feinstein
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/14/2019
Drug-price Transparency in Communications (DTC) Act [S.1437]
Provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency, published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.
S.1437: Drug-price Transparency in Communications (DTC) Act
Sponsored by: Sen. Chuck Grassley
Read Twice And Referred To The Committee On Finance. on 05/13/2019
MORE Savings Act Maximizing Opioid Recovery Emergency Savings Act [S.1424]
Modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance. Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles). The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal
(continued...)
S.1424: MORE Savings Act Maximizing Opioid Recovery Emergency Savings Act
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Finance. on 05/13/2019
SCR-12: An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2020 and setting forth the appropriate budgetary levels for fiscal years 2021 through 2024.
Sponsored by: Sen. Michael Enzi
Committee On The Budget. Original Measure Reported To Senate By Senator Enzi. Without Written Report. (text: Cr S2127-2135) on 04/01/2019
You have voted SCR-12: An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2020 and setting forth the appropriate budgetary levels for fiscal years 2021 through 2024..
Affordable Prescriptions for Patients Act of 2019 [S.1416]
Prohibits patent thicketing and product hopping by drug manufacturers. In general, patent thicketing occurs when a drug manufacturer obtains new patents related to a previously-patented drug, biological product, or underlying chemical composition that extends the manufacturer’s market exclusivity for that drug without demonstrating that the new patents serve a meaningful purpose other than limiting competition from generic drug manufacturers.Product hopping is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration’s
(continued...)
S.1416: Affordable Prescriptions for Patients Act of 2019
Sponsored by: Sen. Martha McSally
Committee On The Judiciary. Reported By Senator Graham With An Amendment In The Nature Of A Substitute. Without Written Report. on 06/28/2019